1、Orion Group Sustainability Report 2019Orion Group Sustainability Report 2019ORION TODAY3CEOs Overview6Our year of sustainability7OUR APPROACH8Sustainability at Orion9Materiality analysis10Values and principles as cornerstones12Sustainable pharmaceutical product lifecycle management13Case:First Carbo
2、n Footprint Assessment of Orions Dry Powder Inhalers15Corporate responsibility governance16Our targets and performance17Our stakeholder groups18PATIENT SAFETY AND ENSURING RELIABLE SUPPLY OF MEDICATIONS19Ensuring patient safety,product safety and reliably supply20Orions responsibility of its product
3、 portfolio20Good operating practices20Ensuring safety in the beginning of the product lifecycle20Ensuring quality in our production21Monitoring quality and safety via pharmacovigilance21Pharmacovigilance operations21Audits to ensure operational quality22Recalling the product23Medicine information24F
4、ighting falsified medicines via serialisation and anti-tampering24Avoiding availability challenges24Management of patient safety25ENVIRONMENT26Manufacturing products in an environmentally sustainable way27Reducing pharmaceutical residues27Enhancing the proper use of medicine27Pharmaceuticals in the
5、environment28Ensuring effective EHS management29Use of materials in our production30Case:How to make sustainable packaging for pharmaceutical products31Targeting energy efficiency32Reducing emissions to combat climate chance32Processing waste in a responsible manner32Monitoring our wastewater34Envir
6、onmental impacts of transportation and travel34Monitoring our environmental performance and investments35Management of environmental performance in own operations36RESPONSIBILITY FOR ORIONEES37Our shared company values38Promoting equality and fairness39Collective bargaining agreements for Finnish em